Filing Flows › Yarrow Bioscience (YARW) › Q2 2026 › vs Q2 2025
Yarrow Bioscience (YARW) Q2 2026 vs Q2 2025 (year over year)
Yarrow Bioscience's revenue rose $28K (+41%) from $69K in Q2 2025 to $97K in Q2 2026.
Yarrow Bioscience, Q2 2026: revenue $97K (+41% year over year), net loss $3.0M, operating cash flow −$2.0M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $97K | $69K | $28K | +41% |
| Other income, net | $95K | $1.8M | −$1.7M | -95% |
| Net loss | $3.0M | $5.8M | −$2.7M | -48% |
| Costs & expenses | $3.2M | $7.6M | −$4.4M | -58% |
| Operating costs | $3.2M | $7.6M | −$4.4M | -58% |
| Research & development | $788K | $4.9M | −$4.1M | -84% |
| General & admin | $2.4M | $2.7M | −$319K | -12% |
| Operating cash sources | $3.0M | $5.8M | −$2.7M | -48% |
| Depreciation & amortization | $6K | $6K | $0 | 0% |
| Share-based compensation | $436K | $529K | −$93K | -18% |
| Working capital & other | $573K | −$5.6M | $6.2M | — |
| Cash used in operations | $2.0M | $10.8M | −$8.8M | -82% |
| Net loss absorbed | $3.0M | $5.8M | −$2.7M | -48% |
Questions
How much did Yarrow Bioscience's revenue grow year over year in Q2 2026?
Yarrow Bioscience's revenue rose $28K (+41%) from $69K in Q2 2025 to $97K in Q2 2026.